128 related articles for article (PubMed ID: 10391086)
1. Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line.
Sato S; Yokozaki H; Yasui W; Nikai H; Tahara E
Jpn J Cancer Res; 1999 May; 90(5):485-9. PubMed ID: 10391086
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation.
Verkaik NS; Trapman J; Romijn JC; Van der Kwast TH; Van Steenbrugge GJ
Int J Cancer; 1999 Jan; 80(3):439-43. PubMed ID: 9935187
[TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.
Hayashi K; Yokozaki H; Goodison S; Oue N; Suzuki T; Lotan R; Yasui W; Tahara E
Differentiation; 2001 Aug; 68(1):13-21. PubMed ID: 11683489
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer.
Kito H; Suzuki H; Ichikawa T; Sekita N; Kamiya N; Akakura K; Igarashi T; Nakayama T; Watanabe M; Harigaya K; Ito H
Prostate; 2001 Oct; 49(2):110-5. PubMed ID: 11582589
[TBL] [Abstract][Full Text] [Related]
12. Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region.
Verkaik NS; van Steenbrugge GJ; van Weerden WM; Bussemakers MJ; van der Kwast TH
Lab Invest; 2000 Aug; 80(8):1291-8. PubMed ID: 10950120
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
Kang YH; Bae SI; Kim WH
J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.
Hamai Y; Oue N; Mitani Y; Nakayama H; Ito R; Matsusaki K; Yoshida K; Toge T; Yasui W
Cancer Sci; 2003 Aug; 94(8):692-8. PubMed ID: 12901794
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
20. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]